1. Home
  2. COOK vs HELP Comparison

COOK vs HELP Comparison

Compare COOK & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Traeger Inc.

COOK

Traeger Inc.

N/A

Current Price

$60.95

Market Cap

170.4M

ML Signal

N/A

Logo Cybin Inc. Common Stock

HELP

Cybin Inc. Common Stock

N/A

Current Price

$8.00

Market Cap

233.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COOK
HELP
Founded
1985
N/A
Country
United States
Canada
Employees
N/A
50
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.4M
233.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
COOK
HELP
Price
$60.95
$8.00
Analyst Decision
Hold
Strong Buy
Analyst Count
5
2
Target Price
$53.00
$51.50
AVG Volume (30 Days)
63.5K
1.7M
Earning Date
05-11-2026
07-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.08
N/A
Revenue
$559,520,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.07
N/A
P/E Ratio
$56.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$3.76
52 Week High
$86.59
$8.55

Technical Indicators

Market Signals
Indicator
COOK
HELP
Relative Strength Index (RSI) 42.48 67.87
Support Level $60.87 $4.18
Resistance Level $76.22 $8.55
Average True Range (ATR) 5.46 0.52
MACD -1.40 0.05
Stochastic Oscillator 17.95 75.00

Price Performance

Historical Comparison
COOK
HELP

About COOK Traeger Inc.

Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: